Robert O. Cotes, MD

  • 4Articles
  • 24.3KReads
  • 2017–2023Active
  • 9Collaborators
  • 43Citations

About

Robert O. Cotes, MD, is affiliated with the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia. His publications, spanning from 2017 to 2023, focus on schizophrenia and schizoaffective disorders, mood disorders, and suicide. His work includes studies on clinical follow-up intervals for long-acting injectable antipsychotics, the protective effects of clozapine on suicide, lithium augmentation strategies following clozapine-induced neutropenia or agranulocytosis, and protocols for clozapine-induced myocarditis screening. He has frequently collaborated with David R. Goldsmith, Brian J. Lee, Frederick C. Nucifora, Jr, Mina Boazak, and Oliver Freudenreich.

Publications

JCP
Clinical Follow-Up and Widening LAI Intervals
Commentary

Clinical Follow-Up and Widening LAI Intervals

May 31, 2023

Although the administration intervals of long-acting injectable antipsychotics are a starting point for scheduling follow-ups, frequency of prescriber contact should be based on individual risk factors and real-world constraints.
, ,
JCP
Protective Effect of Clozapine on Suicide
Original Research

Protective Effect of Clozapine on Suicide

March 15, 2023

Clozapine, which has shown promise in reducing suicidal behavior in schizophrenia, also appears to lower the odds of suicide death in the general population.
, , , et al
PCC
Letter to the Editor

Lithium Augmentation for Clozapine Rechallenge: Discontinuation Might Be Risky

November 29, 2018

Is lithium needed long term after clozapine rechallenge? Do individuals develop neutropenia or agranulocytosis after lithium is discontinued? The authors of this report analyzed all of the available literature...
, ,
PCC
Letter to the Editor

Clozapine-Induced Myocarditis Screening Protocol

August 3, 2017

Clinicians should be able to recognize and manage potential side effects of clozapine, including myocarditis. However, treatment guidelines do not currently recommend a monitoring protocol for clozapine-induced myocarditis. This...
,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe